Shanghai Haohai Biological Technology Co. Ltd. logo

Shanghai Haohai Biological Technology Co. Ltd. (5HB)

Market Closed
11 Aug, 20:00
XFRA XFRA
1. 79
-0.02
-1.105%
1.35B Market Cap
- P/E Ratio
1.6% Div Yield
900 Volume
- Eps
1.81
Previous Close
Add Transaction
Day Range
1.79 1.8
Year Range
1.66 3.24
Want to track 5HB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

5HB closed today lower at €1.79, a decrease of -1.105% from yesterday's close, completing a monthly increase of 7.1856% or €0.12. Over the past 12 months, 5HB stock lost -31.1538%.
5HB is not paying dividends to its shareholders.
The last earnings report, released on Aug 14, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Shanghai Haohai Biological Technology Co. Ltd. has completed 1 stock splits, with the recent split occurring on Jun 06, 2024.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XDUS (EUR).

5HB Chart

People also search for

Zai Lab Limited
2.1
+8.8083%
Ping An Healthcare and Technology Company Limited ADR
1.42
-1.3889%
Ryman Healthcare Limited Unsponsored ADR
4.86
-0.8163%
2LS
Siloam International Hospitals Tbk.
0.11
+2.8571%
Konica Minolta Inc.
3.53
+0.1134%

Shanghai Haohai Biological Technology Co. Ltd. (5HB) FAQ

What is the stock price today?

The current price is €1.79.

On which exchange is it traded?

Shanghai Haohai Biological Technology Co. Ltd. is listed on XFRA.

What is its stock symbol?

The ticker symbol is 5HB.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.6%.

What is its market cap?

As of today, the market cap is 1.35B.

Has Shanghai Haohai Biological Technology Co. Ltd. ever had a stock split?

Shanghai Haohai Biological Technology Co. Ltd. had 1 splits and the recent split was on Jun 06, 2024.

Shanghai Haohai Biological Technology Co. Ltd. Profile

Biotechnology Industry
Healthcare Sector
Dr. Yongtai Hou Ph.D. CEO
XFRA Exchange
CNE100001W69 ISIN
DE Country
2,156 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Shanghai Haohai Biological Technology Co., Ltd., established in 2007 and headquartered in Shanghai, China, stands as a paramount figure in the biomedical materials industry, not only within its domestic borders but also internationally. The company initially known as Haohai Limited until its rebranding in 2010, has carved a niche for itself through its dedication to research, development, manufacture, and sale of a wide range of biomedical products. Engaging in a broad spectrum of sectors, including ophthalmology, medical aesthetics, biological engineering, and pharmaceutical products, Shanghai Haohai Biological Technology Co., Ltd. also extends its expertise to technology transfer and consultation services. This multifaceted approach underscores the company’s commitment to advancing healthcare through innovation.

Products and Services

Shanghai Haohai Biological Technology Co., Ltd.'s portfolio encompasses an extensive array of products and services designed to meet the diverse needs of the medical and healthcare communities:

  • Ophthalmology Products: This range includes intraocular lenses for cataract surgery, medical sodium hyaluronate gel for ophthalmic surgery assistance, and lubricant eye drops for dry eye relief.
  • Sodium Hyaluronate Injection: Primarily used in joint disorders, these injections serve as a lubricant and shock absorber, providing pain relief and improved mobility.
  • Medical Chitosan: This biopolymer has diverse applications, including wound healing and as a biomaterial in tissue engineering.
  • Anti-Adhesion and Burn Wound Products: These products are designed to prevent post-surgical adhesions and aid in the healing of burn wounds, enhancing recovery outcomes.
  • Medical Aesthetics Products: The company’s foray into medical aesthetics includes Matrifill, a first-generation HA dermal filler for skin volume restoration; Janlane, a second-generation HA dermal filler tailored for dynamic wrinkles; and Hyalumatrix, a third-generation HA dermal filler that specializes in precise facial contouring. Additionally, the company offers genetic-engineering preparations for epidermal repair and devices for aesthetic procedures, such as radio frequency and laser equipment.
  • Biological Engineering and Pharmaceutical Products: Engaging in cutting-edge research and development, Shanghai Haohai provides innovative solutions that span biological reagents, biologicals and biological materials. This segment also involves the manufacture and sale of related machinery and accessories.
  • Technology Transfer and Consultation Services: Beyond product development and manufacturing, Shanghai Haohai plays a pivotal role in the dissemination of knowledge and technology, facilitating advancements in medical practices through effective consultation and technology transfer services.

Contact Information

Address: WenGuang Plaza, Shanghai, China
Phone: 86 21 5229 3555